UK: Global Business Innovation Programme in Sweden – Antimicrobial Resistance (AMR)

Innovate UK’s Global Business Innovation Programme aims to help UK businesses to grow and scale on a global stage through building R&D and innovation collaborations and partnerships.

This GBIP consists of a Get ready preparation stage in the UK, a six-day innovation visit to Sweden, an Exploit the opportunity workshop and followup support from an Innovate UK innovation and growth specialist, helping your business maximise the opportunities identified, including developing innovation projects with partners in the region.

Why Sweden?

• The Swedish Government has adopted an updated strategy to combat AMR. The overarching goal continues to be preserving the possibility of effective treatment of bacterial infections in humans and animals. The strategy recognises that Swedish efforts to combat antibiotic resistance at the national, EU and international levels need to be long-term and sustainable and be based on effective initiatives in all relevant areas.
• Sweden continues to show leadership in international efforts, in line with the Swedish Policy for Global Development and global commitments made under the 2030 Agenda for Sustainable Development and EU activities. The strategy is based on ongoing Swedish efforts to combat antibiotic resistance, on the global action plan on antimicrobial resistance adopted by the WHO1 Member States, the FAO2 action plan, the OIE3 strategy and on other relevant plans and strategies such as the EU Action Plan against Antimicrobial Resistance, the IACG4 recommendations and the joint work plan of the Tripartite. The strategy comprises seven “One Health” objectives which closely reflect UK strategic ambitions and this demonstrates that Sweden is an ideal collaborator with UK organisations along with their progress to date in tackling AMR:
  • Objective 1: Increased knowledge through enhanced surveillance
  • Objective 2: Continued strong preventive measures
  • Objective 3: Responsible use of antibiotics
  • Objective 4: Increased knowledge for preventing and managing bacterial infections and antibiotic resistance with new methods
  • Objective 5: Improved awareness and understanding in society of antibiotic resistance and countermeasures
  • Objective 6: Supporting structures and systems
  • Objective 7: Leadership within the EU and international cooperation.

Benefits of Programme

• Explore opportunities for AMR collaboration in Sweden
• Visit major tech clusters to gain a better understanding of the challenges and opportunities of doing business in these markets
• Meet key AMR players
• Find potential innovation collaborators and partners, and develop your network in the UK and globally
• Improve your company value proposition to international partners and investors

Who can apply?

• To participate in this GBIP your business must be an SME and established in the UK. The CEO, founder, or a senior decision maker from the business will be expected to participate in all aspects of the GBIP.

For more information, visit Innovate UK.